Abstract:AIMS To describe the sequence of clinically apparent events causing readmission and antedating death, subsequent to a first-time hospital admission for heart failure, in order to give insights into the natural history and mechanisms of progression of heart failure. METHODS A national database of linked hospital discharge and mortality data for Scotland (population 5.1 million) was used. Patients with a first-time admission to hospital with heart failure in 1992 (index population) were identified and, using a record linkage system, hospital readmissions and their cause according to the hospital physician and deaths were recorded over the subsequent 3 years. A flowchart showing the sequence of events leading to death or recurrent admission was constructed. RESULTS 12 640 patients had first-time admissions with heart failure in 1992; their mean age was 74 years and 46.2% were men. A cohort of 2922 (23%) patients died on their first admission. Among the remaining 9718 patients there were 22 747 readmissions and 4877 deaths over the subsequent 3 years; only 15% had neither event reported. Nine per cent of patients died without any readmission and a further 6% without a further readmission for cardiovascular reasons. A cohort of 5992 (61% of patients at risk) had at least one cardiovascular readmission and half of these had occurred within 6 months. Heart failure without a report of any cardiovascular precipitating event was responsible for 37% (2188 patients) of first cardiovascular readmissions and of these patients approximately 12% had evidence of renal failure or acute respiratory infection as possible triggers for readmission. Acute ischaemic events including myocardial infarction (19%), myocardial infarction alone (8%) and atrial fibrillation (11%) were associated with a substantial number of first readmissions. First readmission precipitated by acute myocardial infarction was associated with a particularly poor prognosis (40% inpatient mortality). CONCLUSIONS Recurrent ischaemic events and atrial fibrillation may be the predominant mechanisms leading to exacerbation of and progression of heart failure and death. A substantial proportion of readmissions appear related to heart failure alone. Whether this reflects progressive ventricular remodelling leading to worsening heart failure or other unidentified mechanisms cannot be discerned from this data.

[Advice as to the safety precautions for handling infectious material in a veterinary practice laboratory].

Ligand Selectivity among the Dopamine and Serotonin Transporters Specified by the Forward Binding Reaction

NH+4 augments net acid secretion by a ouabain-sensitive mechanism in isolated perfused inner medullary collecting ducts.

Modifications to 1-(4-(2-Bis(4-fluorophenyl)methyl)sulfinyl)alkyl Alicyclic Amines That Improve Metabolic Stability and Retain an Atypical DAT Inhibitor Profile

Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges.

Structure-Based Discovery of a Novel Allosteric Inhibitor against Human Dopamine Transporter

Characterization of Novel Pyrovalerone Analogs as Potential Dopamine Transporter Irreversible Ligands

Substrate-induced Conformational Dynamics of the Dopamine Transporter

Cryo-EM structure of the dopamine transporter with a novel atypical non-competitive inhibitor bound to the orthosteric site

Intracellular Binding Site for a Positive Allosteric Modulator of the Dopamine D1 Receptor

A subtle modification of modafinil-based DAT inhibitors changes conformational preference

Ultrasonography for detection of pregnancy and study of embryonic development in heifers.

Controversies and Recent Advances in Hematopoietic Cell Transplantation for Follicular Non-Hodgkin Lymphoma

[Heterogeneity of anti-protein antibodies].

Investigation of cathinone analogs targeting human dopamine transporter using molecular modeling

Structure of the human dopamine transporter and mechanisms of inhibition

Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.

Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters

Piperidine-based nocaine/modafinil hybrid ligands as highly potent monoamine transporter inhibitors: efficient drug discovery by rational lead hybridization

Aromatic linker variations in novel dopamine D2 and D3 receptor ligands

Numerical simulation of fluid flow and heat transfer inside a rotating disk-cylinder configuration by a lattice Boltzmann model.